Cargando…

Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition

Recently, a novel coronavirus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has raised global concerns, being the etiological agent of the current pandemic infectious coronavirus disease 2019 (COVID-19). Specific prophylactic treatments like vaccines, have been authorized f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanna, Vanna, Satta, Sandro, Hsiai, Tzung, Sechi, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755562/ https://www.ncbi.nlm.nih.gov/pubmed/35114539 http://dx.doi.org/10.1016/j.ejmech.2022.114121

Ejemplares similares

Engineering viral genomics and nano-liposomes in microfluidic platforms for patient-specific analysis of SARS-CoV-2 variants
por: Satta, Sandro, et al.
Publicado: (2022)

An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages
por: Satta, Sandro, et al.
Publicado: (2022)

Rapid Detection and Inhibition of SARS‐CoV‐2‐Spike Mutation‐Mediated Microthrombosis
por: Satta, Sandro, et al.
Publicado: (2021)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

α-Glucosidase inhibition by green, white and oolong teas: in vitro activity and computational studies
por: Esposito, Fabio, et al.
Publicado: (2023)

Potent antiviral effect of silver nanoparticles on SARS-CoV-2
por: Jeremiah, Sundararaj S., et al.
Publicado: (2020)

Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies
por: Sanna, Vanna, et al.
Publicado: (2011)

Antiviral Activity of Zinc Oxide Nanoparticles against SARS-CoV-2
por: Wolfgruber, Stella, et al.
Publicado: (2023)

Targeted therapy using nanotechnology: focus on cancer
por: Sanna, Vanna, et al.
Publicado: (2014)

Antiviral drug discovery by targeting the SARS-CoV-2 polyprotein processing by inhibition of the main protease
por: Kandeel, Mahmoud, et al.
Publicado: (2022)

A hybrid of light-field and light-sheet imaging to study myocardial function and intracardiac blood flow during zebrafish development
por: Wang, Zhaoqiang, et al.
Publicado: (2021)

Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load
por: Gonçalves, Antonio, et al.
Publicado: (2020)

Development of novel cationic chitosan-and anionic alginate–coated poly(d,l-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol
por: Sanna, Vanna, et al.
Publicado: (2012)

SARS-CoV-2 Antiviral Therapy
por: Tao, Kaiming, et al.
Publicado: (2021)

Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
por: Santos, Igor de Andrade, et al.
Publicado: (2020)

Molecular Investigation of SARS–CoV-2 Proteins and Their Interactions with Antiviral Drugs
por: Calligari, Paolo, et al.
Publicado: (2020)

SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
por: Liu, Xiaonan, et al.
Publicado: (2021)

Combination of Antiviral Drugs to Inhibit SARS-CoV-2 Polymerase and Exonuclease as Potential COVID-19 Therapeutics
por: Wang, Xuanting, et al.
Publicado: (2021)

Structure and inhibition of SARS-CoV-1 and SARS-CoV-2 main proteases by oral antiviral compound AG7404
por: Fàbrega-Ferrer, Montserrat, et al.
Publicado: (2022)

In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age
por: Lieberman, Nicole A. P., et al.
Publicado: (2020)

Antiviral Lipid Nanocarrier Loaded with Remdesivir Effective Against SARS-CoV-2 in vitro Model
por: Jeon, Woo-Jin, et al.
Publicado: (2023)

Ayurvedic metal nanoparticles could be novel antiviral agents against SARS-CoV-2
por: Sarkar, Prasanta Kumar, et al.
Publicado: (2021)

Discovery of SARS-CoV-2 Antivirals through Large-scale Drug Repositioning
por: Riva, Laura, et al.
Publicado: (2020)

New Approaches and Repurposed Antiviral Drugs for the Treatment of the SARS-CoV-2 Infection
por: Bauso, Luana Vittoria, et al.
Publicado: (2021)

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
por: Bojkova, Denisa, et al.
Publicado: (2022)

An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines
por: Hillary, Varghese Edwin, et al.
Publicado: (2023)

Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication
por: Pirzada, Rameez Hassan, et al.
Publicado: (2021)

Effectiveness of Remdesivir in Comparison with Five Approved Antiviral Drugs for Inhibition of RdRp in Combat with SARS-CoV-2
por: Mahdian, Soodeh, et al.
Publicado: (2022)

Aminoglycosides and their potential as SARS-CoV-2 antivirals
por: Cimolai, Nevio
Publicado: (2021)

SARS-CoV-2 rebound with and without antivirals
por: Petrosillo, Nicola
Publicado: (2023)

Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
por: Jeon, Sangeun, et al.
Publicado: (2020)

Potential of Azadirachta indica as a Capping Agent for Antiviral Nanoparticles against SARS-CoV-2
por: Foka, Frank Eric Tatsing, et al.
Publicado: (2022)

Seeking antiviral drugs to inhibit SARS-CoV-2 RNA dependent RNA polymerase: A molecular docking analysis
por: Khater, Ibrahim, et al.
Publicado: (2022)

Antiviral zinc oxide nanoparticles mediated by hesperidin and in silico comparison study between antiviral phenolics as anti-SARS-CoV-2
por: Attia, Gouda H., et al.
Publicado: (2021)

Initiation of Antiviral Treatment in SARS‐CoV2: Modeling Viral Dynamics and Drug Properties
por: Rosenbloom, Daniel Scholes, et al.
Publicado: (2020)

Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets
por: Park, Su-Jin, et al.
Publicado: (2020)

Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus
por: Terrier, Olivier, et al.
Publicado: (2021)

QTc interval prolongation in patients infected with SARS-CoV-2 and treated with antiviral drugs()()
por: Esmel-Vilomara, Roger, et al.
Publicado: (2022)

Combining antiviral drugs with BET inhibitors is beneficial in combatting SARS‐CoV‐2 infection
por: Acharya, Arpan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_88vb0v0b5gi53bvmk6nmf702f0